英文
1. Soluble
macromolecular carriers for the delivery of antitumor drugs.
Hitoshi
Sezaki, Yoshinobu Takakura, and Mitsuru Hashida
Advanced
Drug Delivery Reviews, 3, 247-266 (1989)
2. Blood-brain
barrier: Transport studies in isolated brain capillaries and in cultured brain
endothelial cells.
Yoshinobu
Takakura, K.L. Audus, and R.T. Borchardt
Advances
in Pharmacology, 22, 137-165 (1991)
3. Macromolecular drug carrier systems in cancer
chemotherapy :macromolecular prodrugs.
Yoshinobu
Takakura, and Mitsuru Hashida
Critical
Reviews in Oncology and Hematology, 18, 207-231 (1995)
4. Delivery
of plasmid DNA to endothelial cells.
Yoshinobu
Takakura, and Mitsuru Hashida
European
Journal of Pharmaceutics and Biopharmaceutics, 42(4), 269-276 (1996)
5. Macromolecular
carrier systems for targeted drug delivery: Pharmacokinetic considerations on
biodistribition.
Yoshinobu
Takakura, and Mitsuru Hashida
Pharmaceutical
Research, 13(6), 820-831 (1996)
6. Control
of pharmacokinetic profiles of drug-macromolecule conjugates.
Yoshinobu
Takakura, Ram I. Mahato, Makiya Nishikawa, and Mitsuru Hashida
Advanced
Drug Delivery Reviews, 19(3), 377-399 (1996)
7. Pharmacokinetic
evaluation of polymeric carriers.
Makiya
Nishikawa, Yoshinobu Takakura, and Mitsuru Hashida
Advanced
Drug Delivery Reviews, 21(2), 135-155 (1996)
8. Nonviral
vectors for in vivo gene delivery: Physicochemical and pharmacokinetic
considerations.
Ram I.
Mahato, Yoshinobu Takakura, and Mitsuru Hashida
Critical
Reviews in Therapeutic Drug Carrier Systems, 14(2), 133-172 (1997)
9. Development
of targeted delivery systems for nucleic acid drugs.
Ram I.
Mahato, Yoshinobu Takakura, and Mitsuru Hashida
Journal
of Drug Targeting, 4(6), 337-357 (1997)
10. Delivery
systems for gene drugs: The key to success of in vivo gene therapy.
Yoshinobu
Takakura, and Mitsuru Hashida
Controlled
Release Newsletter, 15(1), 5-7 (1998)
11. Extravasation
of macromolecules.
Yoshinobu
Takakura, Ram I. Mahato, and Mitsuru Hashida
Advanced
Drug Delivery Reviews, 34(1), 93-108 (1998)
12. Development
of gene drug delivery systems based on pharmacokinetic studies.
Yoshinobu Takakura, Makiya
Nishikawa, Fumiyoshi Yamashita, and Mitsuru Hashida
European
Journal of Pharmaceutical Sciences, 13, 71-76 (2001)
13. Cell-specific
delivery of genes with glycosylated carriers.
Mitsuru Hashida, Makiya Nishikawa,
Fumiyoshi Yamashita, and Yoshinobu Takakura
Advanced Drug Delivery Reviews,
52(3), 187-196 (2001)
14. Influence of physicochemical properties on
pharmacokinetics of non-viral vectors for gene delivery
Yoshinobu Takakura, Makiya
Nishikawa, Fumiyoshi Yamashita and Mitsuru
Hashida
Journal of Drug Targeting, 10(2),
99-104 (2002)
15. Analysis methods and recent advances in nonlinear pharmacokinetics from
in vitro through in loci to in vivo
Kiyoshi Yamaoka and Yoshinobu
Takakura
Drug Metabolism and Pharmacokinetics,
19(6), 397-406 (2004)
16. Pharmacokinetics in gene delivery
Yoshinobu Takakura and Mitsuru
Hashida
Advanced Drug Delivery Reviews, 57(5),
667-668 (2005)
17. Theoretical considerations involving the
pharmacokinetics of plasmid DNA
Makiya Nishikawa, Yoshinobu
Takakura and Mitsuru Hashida
Advanced Drug Delivery Reviews, 57(5),
675-688 (2005)
18. The hydrodynamics-based procedure for controlling the pharmacokinetics
of gene medicines at whole body, organ and cellular levels
Naoki Kobayashi, Makiya
Nishikawa, Yoshinobu Takakura
Advanced Drug Delivery Reviews, 57(5),
713-731 (2005)
19. Pharmacokinetics of Plasmid DNA-Based
Non-viral Gene Medicine
Makiya Nishikawa, Yoshinobu
Takakura and Mitsuru Hashida
Advances in Genetics, 53, 47-68
(2005)
20. Role of immunostimulatory DNA and
TLR9 in gene therapy
Kei Yasuda, Hermann Wagner and
Yoshinobu Takakura
Critical Reviews in Therapeutic
Drug Carrier Systems, 23, 89-109 (2006)
21. HSP-based tumor vaccines: state-of-the-art
and future directions
Yoshinobu
Takakura, Seiji Takemoto and Makiya Nishikawa
Current Opinion in Molecular Therapeutics, 9(4) 385-391 (2007)
22. Heat Shock Protein Derivatives for Delivery
of Antigens to Antigen Presenting Cells
Makiya
Nishikawa, Seiji Takemoto and Yoshinobu Takakura
International Journal of Pharmaceutics, 354(1-2), 23-7 (2007)
23. Pharmacokinetic
considerations regarding nonviral cancer gene therapy
Makiya
Nishikawa, Yoshinobu Takakura, Mitsuru Hashida
Cancer Science, 99(5), 856-62 (2008)
24. Catalase delivery for inhibiting
ROS-mediated tissue injury and tumor metastasis
Makiya Nishikawa, Mitsuru Hashida, Yoshinobu Takakura
Advanced Drug Delivery Reviews, 61(4), 319-26 (2009)
25. Towards Therapeutic
Application of RNA-mediated Gene Regulation.
Yoshinobu Takakura
Advanced Drug Delivery Reviews, 61, 667 (2009)
26. Nonviral
vector-mediated RNA interference: its gene silencing characteristics and
important factors to achieve RNAi-based gene therapy
Yuki Takahashi, Makiya Nishikawa, Yoshinobu Takakura
Advanced Drug Delivery Reviews, 61, 760-766 (2009)
27. DNA-based nano-sized systems for
pharmaceutical and biomedical applications
Makiya Nishikawa,
Sakulrat Rattanakiat, Yoshinobu Takakura
Advanced Drug Delivery
Reviews, 62(6):626-32 (2010)
28. Development of safe and effective nonviral gene therapy by eliminating
CpG motifs from plasmid DNA vector
Yuki Takahashi, Makiya Nishikawa, Yoshinobu Takakura
Frontiers in Bioscience, 4:133-41 (2012)
29. Nucleic Acid Drug Delivery and Targeting
Yoshinobu Takakura
Pharmaceutical Research,
28(4):691-693 (2011)
30. Guest
Editorial: Professor Mitsuru Hashida: His
outstanding achievements in drug delivery research
Yoshinobu
Takakura
Journal
of Drug Targeting, 20(9):722-3 (2012)
31. Controlling
the kinetics of interferon transgene expression for improved gene therapy
Kanitta
Watcharanurak, Makiya Nishikawa, Yuki Takahashi, Yoshinobu Takakura
Journal
of Drug Targeting, 20(9):764-9 (2012)
32.
DNA nanotechnology-based development of delivery systems for bioactive
compounds
Kohta
Mohri, Makiya Nishikawa, Yuki Takahashi, and Yoshinobu Takakura
European
Journal of Pharmaceutical Sciences, 58:26-33 (2014)
33.
A Tribute to Ronald T. Borchardt-Teacher, Mentor, Scientist, Colleague, Leader,
Friend, and Family Man
Schowen KB, Schowen RL, Borchardt SE,
Borchardt PM, Artursson P, Audus KL, Augustijns P, Nicolazzo JA, Raub TJ,
Schöneich C, Siahaan TJ, Takakura Y,
Thakker DR, Wolfe MS.
Journal
of Pharmaceutical Sciences, 105(2), 370-385 (2015)
34. Pharmacokinetics of Exosomes - an Important Factor for Elucidating
the Biological Roles of Exosomes and for the Development of Exosome-Based
Therapeutics
Masaki Morishita, Yuki Takahashi, Makiya Nishikawa, and Yoshinobu Takakura
Journal of Pharmaceutical Sciences, 106(9):2265-2269 (2017)
35. Possibility of exosome-based therapeutics and challenges in production
of exosomes eligible fo therapeutic application
Takuma Yamashita, Yuki Takahashi, Yoshinobu Takakura
Biological and Pharmaceutical Bulletin, 41(6):835-842 (2018)
36. Therapeutic application of small extracellular vesicles (sEVs): Pharmaceutical
and pharmacokinetic challenges
Yoshinobu Takakura, Akihiro Matsumoto, Yuki Takahashi
Biological and Pharmaceutical Bulletin, 43(4):576-583 (2020)
和文
1. 遺伝子医薬品のDDS開発とその問題点
高倉喜信，橋田 充
Drug
Delivery System, 10(6), 391-398 (1995)
2. 高分子薬物のデリバリーシステムの開発に関する研究
高倉喜信
薬学雑誌,
116(7), 519-532 (1996)
3. 体内・細胞内動態制御機能を搭載した熱ショックタンパク質の開発とワクチンデリバリーへの応用
西川元也、竹本誠二、高倉喜信
薬学雑誌,
127(2), 293-300 (2007)
4. がん細胞へのsiRNAデリバリーとがん遺伝子治療への適用
高橋有己、西川元也、高倉喜信
薬学雑誌, 127(10),
1525-1531 (2007)
5. 発現タンパク質の時空間制御による遺伝子治療効果の最適化
西川元也、高橋有己、高倉喜信
薬学雑誌, 130(11),
1505-1511 (2010)
6. . 機能性ペプチド融合によるIFNγ時空間制御
安藤 満、高橋有己、西川元也、高倉喜信
薬学雑誌, 132(12),
1399-1406 (2012)
7. . DDSに資するエキソソームの開発
森下将輝、高橋有己、西川元也、高倉喜信
膜（Membrane）, 40(5), 248-253
(2015)
8. . DDS
を指向したexosome 体内動態の解析と制御
高橋有己、西川元也、高倉喜信
薬学雑誌,
136(1):49-53 (2016)
9. . 学術会議報告の概要
高倉喜信
薬学雑誌, 139(3); 395-400 (2019)
